Tick-Borne Disease Working Group Special Issue SECTION

Why We Care About the Safety and Efficacy of Lyme Disease Vaccines

Tick-Borne Disease Working Group Special Issue

Why We Care About the Safety and Efficacy of Lyme Disease Vaccines

You don’t have to be an “anti-vaxxer” in order to raise questions about Lyme disease vaccines.

By Phyllis Mervine

READ STORY
How the LYMErix Lyme Disease Vaccine was Pulled from the Market

Tick-Borne Disease Working Group Special Issue

How the LYMErix Lyme Disease Vaccine was Pulled from the Market

Patricia Smith, president of LDA, identifies lessons we can learn from the LYMErix Lyme disease vaccine story and pitfalls we can hopefully avoid in the future.

By Pat Smith

READ STORY
Minority Opinion Is a Critical Element of the Tick-Borne Disease Working Group Report

Tick-Borne Disease Working Group Special Issue

Minority Opinion Is a Critical Element of the Tick-Borne Disease Working Group Report

A summary of how minority opinions influenced the Tick-Borne Disease Working Groups views on vaccines, treatment, and diagnosising Lyme disease.

By Phyllis Mervine

READ STORY
Balanced Lyme Disease Stories Benefit Tick-Borne Disease Working Group

Tick-Borne Disease Working Group Special Issue

Balanced Lyme Disease Stories Benefit Tick-Borne Disease Working Group

The purpose of having balanced Lyme disease stories from Lyme patients is to provide some human interest to incentivize Congress to fund Lyme disease research.

By Phyllis Mervine

READ STORY

EXPLORE LYMETIMES

Most Popular Articles

NEWSLETTER SIGN UP

Subscribe to our mailing list and get Lyme disease news updates to your email inbox.

We respect your privacy and take protecting it seriously.